Key result
LAAO allows 1-day discharge in ~50% of patients, with delays linked to adverse events and higher HAS-BLED.
Why the study?
Factors influencing the length of stay in patients undergoing percutaneous LAAO were evaluated.
What factors influence the length of stay in patients undergoing percutaneous left atrial appendage occlusion?
Observational (n=1,076)
Yes
What factors influence the length of stay in patients undergoing percutaneous left atrial appendage occlusion?
Answers are grounded in this paper and cite their sources.
Over half of patients undergoing LAAO with the Amplatzer Amulet occluder can be safely discharged within 1 day, with prolonged stays primarily driven by procedure-related serious adverse events and higher baseline HAS-BLED scores.
AIMS: To evaluate factors influencing the length of stay in patients undergoing percutaneous left atrial appendage occlusion (LAAO). METHODS AND RESULTS: Patient characteristics, procedural data and the occurrence of serious adverse events were analyzed from the AmplatzerTM AmuletTM Occluder Observational Study. Patients were divided into three groups: same day (S, 0day, n = 60, 5.6%) early (E, 1day, n = 526, 48.9%), regular (R, 2-3days, n = 338, 31.4%) and late (L, ≥4days, n = 152, 14.1%) discharge and followed up for 60 days. Procedure and device related SAE during the in-hospital stay (S: 0.0% vs. E: 1.0% vs. R: 2.1% vs. L: 23%, p<0.0001) were a major trigger for a prolonged in-hospital stay. Of the 37 subjects in the late discharge group with an SAE prior to discharge, cardiac or bleeding complications were the most common underlying conditions, occurring in 26 subjects. Multinomial logistic analysis only identified HAS-BLED score as an independent influencing factor (p = 0.04) for a late discharge. After 60 days, mortality tended to be greatest in the late discharge group (S: 0.0% vs. E: 1.0% vs. R: 1.2% vs. L: 3.3%, p = 0.1066). CONCLUSION: Over half of the subjects receiving an Amplatzer Amulet occluder were discharged within 1 day of the implant procedure. Serious adverse events were a major trigger for a late discharge after LAAO. Increased HAS-BLED score was associated with a prolonged in-hospital stay.
No takes yet. Share an insight, caveat, or question.
Piayda et al. (2021) conducted an observational in Patients undergoing percutaneous left atrial appendage occlusion (LAAO) (n=1,076). Percutaneous left atrial appendage occlusion (Amplatzer Amulet Occluder) vs. Length of stay groups (same day, early, regular, late discharge) was evaluated on Procedure and device related serious adverse events during the in-hospital stay across discharge groups (p=<0.0001). Percutaneous left atrial appendage occlusion allowed discharge within 1 day for over half of patients, with serious adverse events and higher HAS-BLED scores driving late discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: